NCT05392231View on ClinicalTrials.gov

Assessment of Fetal Pancreatic Size and Maternal Serum Biomarkers in GDM

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

April 30, 2022

Study Completion Date

May 10, 2022

Conditions
Gestational Diabetes
Trial Locations (1)

Unknown

Haseki Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Haseki Training and Research Hospital

OTHER